MENU
SNDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SNDX is expected to report earnings to rise 12.73% to -124 cents per share on May 12

Syndax Pharmaceuticals SNDX Stock Earnings Reports
Q1'25
Est.
$-1.24
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.14
The last earnings report on March 03 showed earnings per share of -110 cents, missing the estimate of -83 cents. With 188.84K shares outstanding, the current market capitalization sits at 1.12B.
View a ticker or compare two or three
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com